scPharmaceuticals Profit Margin

The latest profit margin for SCPH is -183.55% as of June 2025. That compares with -252.18% in the prior-year period — up 27.2% year over year. That is below the Healthcare sector average of 13.39%. Investors often review this figure alongside scPharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, SCPH's profit margin moved from -252.18% to -183.55% — a 27.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in scPharmaceuticals's valuation or profitability profile.

Against Healthcare companies, SCPH currently prints -183.55% for profit margin, while the sector average sits near 13.39%. That is roughly 1471.2% below the sector mean. Large gaps often invite a closer look at scPharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively scPharmaceuticals converts resources into returns. At -183.55%, SCPH may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -252.18% in the prior-year period — up 27.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SCPH's profit margin (-183.55%), review year-over-year change from -252.18%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.